DOCSLIB.ORG

Affymetrix Probe ID Gene Symbol Vehicle 6H Raw Data 6Μm CHR-2797 6H Raw Data 6Μm CHR-2797 6H Fold Change 6Μm CH

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Affymetrix Probe ID Gene Symbol Vehicle 6H Raw Data 6Μm CHR-2797 6H Raw Data 6Μm CHR-2797 6H Fold Change 6Μm CH Affymetrix Probe Gene Symbol Vehicle 6h 6µM CHR-2797 6µM CHR-2797 6µM CHR-2797 6µM CHR-2797 Genbank ID ID Raw Data 6h Raw 6h 24h Raw 24h Data Fold Change Data Fold Change 217127_at CTH 20.6 361.0 17.2 263.2 10.7 AL354872 223195_s_at SESN2 30.9 484.0 15.3 425.4 11.4 BF131886 202887_s_at DDIT4 177.2 2303.7 12.7 2235.7 10.5 NM_019058 219270_at MGC4504 16.3 158.6 9.5 144.2 7.4 NM_024111 203438_at STC2 26.0 243.7 9.2 296.6 9.5 AI435828 209921_at SLC7A11 182.7 1638.9 8.8 1173.7 5.3 AB040875 1555788_a_at TRIB3 51.6 399.5 7.6 518.7 8.4 AF250311 206085_s_at CTH 15.4 114.4 7.2 100.0 5.4 NM_001902 217678_at SLC7A11 214.2 1447.0 6.6 1074.2 4.2 AA488687 202672_s_at ATF3 24.8 155.4 6.1 117.9 4.0 NM_001674 218145_at TRIB3 351.3 2059.8 5.7 2518.9 6.0 NM_021158 204359_at FLRT2 21.8 118.7 5.3 397.8 15.2 NM_013231 200920_s_at BTG1 190.2 926.0 4.8 973.9 4.3 AL535380 227014_at LOC57168 13.9 65.6 4.6 128.7 7.7 BE550881 231202_at ALDH1L2 12.2 56.4 4.5 120.4 8.2 AI654224 200921_s_at BTG1 187.4 855.5 4.5 963.5 4.3 NM_001731 227755_at 34.0 154.7 4.4 226.0 5.5 AA042983 225626_at PAG1 102.3 445.1 4.3 1027.4 8.4 AK000680 209822_s_at VLDLR 106.3 454.9 4.2 396.2 3.1 L22431 221156_x_at CCPG1 57.1 242.1 4.1 564.0 8.2 NM_004748 204286_s_at PMAIP1 230.3 968.0 4.1 529.7 1.9 NM_021127 227404_s_at EGR1 285.3 1169.2 4.0 283.3 -1.2 AI459194 201694_s_at EGR1 94.8 386.1 4.0 74.1 -1.5 NM_001964 202847_at PCK2 67.0 270.7 4.0 430.6 5.3 NM_004563 230493_at TMEM46 26.2 102.9 3.8 228.3 7.3 AW664964 210105_s_at FYN 51.5 201.8 3.8 402.8 6.5 M14333 221778_at KIAA1718 20.8 81.5 3.8 81.4 3.3 BE217882 222156_x_at CCPG1 19.0 74.2 3.8 331.0 14.5 AK022459 205047_s_at ASNS 565.5 2193.0 3.8 2664.6 3.9 NM_001673 221698_s_at CLEC7A 11.1 42.9 3.8 242.7 18.2 AF313468 222732_at TRIM39 53.0 201.3 3.7 179.3 2.8 BF514859 208763_s_at TSC22D3 52.9 194.2 3.6 272.9 4.3 AL110191 Affymetrix Probe Gene Symbol Vehicle 6h 6µM CHR-2797 6µM CHR-2797 6µM CHR-2797 6µM CHR-2797 Genbank ID ID Raw Data 6h Raw 6h 24h Raw 24h Data Fold Change Data Fold Change 212486_s_at FYN 13.8 50.5 3.6 73.0 4.4 N20923 204633_s_at RPS6KA5 41.3 150.4 3.6 210.6 4.2 AF074393 210512_s_at VEGF 416.0 1474.2 3.5 2048.9 4.1 AF022375 220924_s_at SLC38A2 570.1 2011.5 3.5 1777.9 2.6 NM_018976 205194_at PSPH 71.8 252.8 3.4 257.4 3.0 NM_004577 221881_s_at CLIC4 28.9 100.9 3.4 110.4 3.2 AI638420 213672_at MARS 25.6 89.3 3.4 84.6 2.7 AA621558 37028_at PPP1R15A 28.3 97.0 3.4 155.4 4.6 U83981 226181_at TUBE1 175.0 592.2 3.3 541.6 2.6 AI613127 201961_s_at RNF41 66.6 224.2 3.3 131.3 1.6 AL583171 225327_at FLJ10980 19.9 66.6 3.3 139.6 5.8 AB037791 212171_x_at VEGF 83.6 279.4 3.3 339.6 3.4 H95344 202557_at STCH 252.1 836.7 3.2 1092.3 3.6 AI718418 225622_at PAG1 39.4 130.2 3.2 263.0 5.6 AI860212 212292_at SLC7A1 15.0 49.4 3.2 37.1 2.1 AW452623 1566901_at TGIF 26.7 87.9 3.2 71.1 2.2 AL832409 218041_x_at SLC38A2 669.1 2185.9 3.2 2116.7 2.6 NM_018573 201925_s_at DAF 159.2 517.0 3.2 561.6 2.9 NM_000574 220892_s_at PSAT1 737.3 2394.0 3.2 2073.1 2.3 NM_021154 201560_at CLIC4 176.0 569.8 3.2 582.2 2.8 NM_013943 228789_at MTMR6 12.1 39.1 3.2 38.5 2.6 AI290971 202770_s_at CCNG2 12.6 40.3 3.1 148.5 9.8 NM_004354 243296_at PBEF1 24.4 78.3 3.1 149.8 5.1 AA873350 204411_at KIF21B 94.4 298.7 3.1 363.6 3.2 NM_017596 225142_at KIAA1718 21.1 66.6 3.1 61.5 2.4 AW294022 205048_s_at PSPH 14.9 47.1 3.1 30.2 1.7 NM_003832 222982_x_at SLC38A2 870.1 2737.1 3.1 2576.4 2.5 AF298897 211506_s_at IL8 582.9 1826.6 3.1 1647.1 2.4 AF043337 203349_s_at ETV5 80.0 250.5 3.1 246.9 2.6 NM_004454 217635_s_at POLG 25.9 80.6 3.0 53.4 1.7 AA769006 226449_at FLJ36090 36.7 113.7 3.0 143.5 3.3 AI392933 221511_x_at CCPG1 34.0 104.6 3.0 419.2 10.3 AB033080 Affymetrix Probe Gene Symbol Vehicle 6h 6µM CHR-2797 6µM CHR-2797 6µM CHR-2797 6µM CHR-2797 Genbank ID ID Raw Data 6h Raw 6h 24h Raw 24h Data Fold Change Data Fold Change 231183_s_at JAG1 78.8 241.6 3.0 282.7 3.0 AI457817 225283_at ARRDC4 41.9 126.6 3.0 78.1 1.6 AV701177 228490_at ABHD2 22.0 65.7 2.9 80.3 3.0 AW292816 226419_s_at SFRS1 23.2 69.3 2.9 112.9 4.1 AA046439 228867_at TATDN3 91.3 272.8 2.9 302.1 2.8 BE541548 211527_x_at VEGF 38.5 114.4 2.9 178.7 3.9 M27281 243869_at KIAA1509 17.2 51.1 2.9 25.2 1.2 AW205685 216268_s_at JAG1 337.9 995.7 2.9 1187.3 2.9 U77914 203080_s_at BAZ2B 17.1 50.3 2.9 69.4 3.4 NM_013450 230164_at ZNF621 20.1 58.5 2.8 57.5 2.4 AA417970 238790_at LOC374443 11.6 33.6 2.8 30.9 2.2 BE738988 204285_s_at PMAIP1 427.7 1237.4 2.8 830.4 1.6 AI857639 203725_at GADD45A 225.9 650.8 2.8 807.7 3.0 NM_001924 224785_at MGC29814 40.1 115.4 2.8 176.7 3.7 AI024869 214684_at MEF2A 51.0 146.3 2.8 122.1 2.0 X63381 238902_at LOC115294 11.2 31.9 2.8 34.0 2.5 T85248 228966_at PANK2 14.2 40.4 2.8 36.4 2.1 BE674076 239331_at 18.2 51.6 2.8 38.4 1.8 AW954199 244377_at SLC1A4 16.8 47.3 2.7 57.8 2.9 AA724708 232665_x_at 16.9 47.3 2.7 9.5 -2.1 AL137424 244132_x_at ZNF518 35.1 98.3 2.7 119.2 2.8 AI267414 209099_x_at JAG1 415.7 1162.4 2.7 1527.5 3.1 U73936 235162_at MDM4 17.1 47.7 2.7 44.0 2.1 AW269813 209098_s_at JAG1 35.0 97.7 2.7 131.1 3.1 U61276 226756_at FLJ36031 14.8 41.3 2.7 80.3 4.5 AA191741 233810_x_at PRO1268 11.4 31.6 2.7 30.0 2.2 AF113017 201559_s_at CLIC4 50.4 140.3 2.7 159.7 2.6 AF109196 200628_s_at WARS 326.6 908.2 2.7 1700.9 4.3 M61715 228235_at MGC16121 17.8 49.2 2.7 34.2 1.6 BE048571 204351_at S100P 473.2 1309.6 2.7 4258.0 7.5 NM_005980 226307_at TORC2 11.5 31.6 2.7 33.5 2.4 AW504757 202558_s_at STCH 161.6 442.7 2.7 493.1 2.5 NM_006948 Affymetrix Probe Gene Symbol Vehicle 6h 6µM CHR-2797 6µM CHR-2797 6µM CHR-2797 6µM CHR-2797 Genbank ID ID Raw Data 6h Raw 6h 24h Raw 24h Data Fold Change Data Fold Change 209795_at CD69 33.6 91.4 2.7 73.3 1.8 L07555 212225_at EIF1 26.4 71.8 2.7 63.1 2.0 AL516854 224097_s_at F11R 15.4 41.7 2.6 81.3 4.4 AF191495 242618_at HCG18 33.0 88.6 2.6 106.4 2.7 AA430072 233559_s_at WDFY1 13.9 37.1 2.6 51.5 3.1 AK023415 218800_at SRD5A2L 11.4 30.5 2.6 25.8 1.9 NM_024592 202720_at TES 242.2 646.9 2.6 966.0 3.3 NM_015641 224839_s_at GPT2 157.9 421.3 2.6 379.0 2.0 BG328998 213300_at KIAA0404 32.2 85.9 2.6 46.6 1.2 AW168132 215501_s_at DUSP10 11.3 30.0 2.6 20.7 1.5 AK022513 218912_at GCC1 99.2 263.6 2.6 281.7 2.4 NM_024523 212971_at CARS 884.4 2348.1 2.6 2640.7 2.5 AI769685 210336_x_at ZNF42 18.5 49.0 2.6 33.8 1.5 AF055078 220358_at SNFT 82.6 217.0 2.6 251.2 2.5 NM_018664 212501_at CEBPB 637.1 1673.9 2.6 2406.3 3.1 AL564683 242918_at NASP 12.8 33.7 2.6 42.5 2.8 AU144734 203348_s_at ETV5 92.8 243.4 2.6 295.3 2.7 BF060791 224783_at MGC29814 67.4 176.3 2.6 351.0 4.3 AA831661 210772_at FPRL1 20.1 52.4 2.6 74.2 3.1 M88107 201926_s_at DAF 115.0 299.9 2.6 361.4 2.6 BC001288 200924_s_at SLC3A2 216.2 563.5 2.5 410.1 1.6 NM_002394 225056_at SIPA1L2 13.3 34.7 2.5 54.6 3.4 AB037810 217591_at SKIL 23.3 60.5 2.5 110.9 4.0 BF725121 202859_x_at IL8 1313.5 3412.6 2.5 3226.9 2.0 NM_000584 230099_at SH3GLP2 19.1 49.4 2.5 52.9 2.3 AI139993 208503_s_at GATAD1 89.1 230.2 2.5 186.7 1.7 NM_021167 213922_at TTBK2 15.1 38.9 2.5 30.0 1.7 AW294686 210513_s_at VEGF 40.2 103.7 2.5 154.0 3.2 AF091352 219957_at RUFY2 10.8 27.9 2.5 17.1 1.3 NM_017987 227109_at CYP2R1 109.0 280.5 2.5 527.7 4.0 AV700558 235069_at TATDN3 27.2 69.9 2.5 63.5 1.9 AL525367 238041_at TCF12 23.2 59.4 2.5 58.0 2.1 AA151712 Affymetrix Probe Gene Symbol Vehicle 6h 6µM CHR-2797 6µM CHR-2797 6µM CHR-2797 6µM CHR-2797 Genbank ID ID Raw Data 6h Raw 6h 24h Raw 24h Data Fold Change Data Fold Change 230102_at ETV5 111.1 284.9 2.5 315.9 2.4 AW206458 222408_s_at YPEL5 24.2 62.1 2.5 216.3 7.4 BC000836 218532_s_at FLJ20152 21.9 56.2 2.5 115.1 4.4 NM_019000 1569366_a_at ZNF569 23.9 61.2 2.5 51.6 1.8 BC038737 202147_s_at IFRD1 204.8 523.8 2.5 819.3 3.3 NM_001550 218559_s_at MAFB 17.1 43.6 2.5 237.4 11.6 NM_005461 232431_at NR3C1 21.4 54.5 2.5 49.9 1.9 AI934556 239289_x_at KIAA1018 19.8 50.5 2.5 46.5 2.0 AI682377 226603_at SAMD9L 13.0 33.1 2.5 47.4 3.0 BE966604 203543_s_at KLF9 34.5 87.4 2.5 45.8 1.1 NM_001206 214753_at PFAAP5 67.8 171.5 2.5 172.4 2.1 AW084068 238774_at LOC284058 31.1 78.6 2.5 118.5 3.2 AW960454 206668_s_at SCAMP1 41.5 104.5 2.5 37.7 -1.3 NM_004866 230786_at 32.4 81.4 2.5 51.0 1.3 AI424786 1555761_x_at RBM15 27.8 70.0 2.5 36.9 1.1 AF364037 214716_at BMP2K 12.0 30.2 2.5 16.2 1.1 AW504018 202794_at INPP1 83.1 208.4 2.5 226.5 2.3 NM_002194 241885_at TAF15 14.9 37.3 2.5 47.1 2.6 BF431050 226735_at FLJ90013 30.4 76.2 2.4 98.8 2.7 AI239899 232352_at ISL2 93.2 233.0 2.4 142.3 1.3 AK001022 202402_s_at CARS 132.8 331.8 2.4 369.0 2.3 NM_001751 204998_s_at ATF5 41.7 104.1 2.4 254.1 5.1 NM_012068 208786_s_at MAP1LC3B 109.1 272.2 2.4 590.6 4.5 AF183417 224394_at RNF7 16.6 41.3 2.4 27.9 1.4 AF312226 227354_at PAG1 42.1 105.0 2.4 269.1 5.3 BF589359 238063_at FLJ32028 72.8 181.5 2.4 296.1 3.4 AA806283 209409_at GRB10 283.6 706.2 2.4 576.9 1.7 D86962 212594_at PDCD4 30.1 75.0 2.4 70.4 1.9 AI185160 216960_s_at ZNF133 23.6 58.6 2.4 49.5 1.7 AL049646 203574_at NFIL3 137.8 342.0 2.4 381.0 2.3 NM_005384 1553158_at MGC14126 31.5 78.2 2.4 92.9 2.5 AY099509 242343_x_at ZNF518 40.2 99.5 2.4 153.1 3.2 H57111 Affymetrix Probe Gene Symbol Vehicle 6h 6µM CHR-2797 6µM CHR-2797 6µM CHR-2797 6µM CHR-2797 Genbank ID ID Raw Data 6h Raw 6h 24h Raw 24h Data Fold Change Data Fold Change 235459_at 33.5 82.8 2.4 102.0 2.5 BF114745 222585_x_at LOC51315 25.5 63.0 2.4 117.5 3.8 BE326678 221985_at KLHL24 15.0 37.0 2.4 21.5 1.2 AW006750 243444_at SRD5A2L 12.6 31.0 2.4 23.9 1.6 AI221894 243309_at FLJ27352 23.6 58.3 2.4 150.6 5.3 AA398658 201009_s_at TXNIP 166.0 409.3 2.4 588.3 2.9 AI439556 224470_at SEC22L3 17.5 43.2 2.4 37.9 1.8 BC006178 240239_at ZNF566 18.5 45.4 2.4 30.0 1.4 N63953 244778_x_at M11S1 18.7
Load more

Recommended publications
  • Propranolol-Mediated Attenuation of MMP-9 Excretion in Infants with Hemangiomas
    Supplementary Online Content Thaivalappil S, Bauman N, Saieg A, Movius E, Brown KJ, Preciado D. Propranolol-mediated attenuation of MMP-9 excretion in infants with hemangiomas. JAMA Otolaryngol Head Neck Surg. doi:10.1001/jamaoto.2013.4773 eTable. List of All of the Proteins Identified by Proteomics This supplementary material has been provided by the authors to give readers additional information about their work. © 2013 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 10/01/2021 eTable. List of All of the Proteins Identified by Proteomics Protein Name Prop 12 mo/4 Pred 12 mo/4 Δ Prop to Pred mo mo Myeloperoxidase OS=Homo sapiens GN=MPO 26.00 143.00 ‐117.00 Lactotransferrin OS=Homo sapiens GN=LTF 114.00 205.50 ‐91.50 Matrix metalloproteinase‐9 OS=Homo sapiens GN=MMP9 5.00 36.00 ‐31.00 Neutrophil elastase OS=Homo sapiens GN=ELANE 24.00 48.00 ‐24.00 Bleomycin hydrolase OS=Homo sapiens GN=BLMH 3.00 25.00 ‐22.00 CAP7_HUMAN Azurocidin OS=Homo sapiens GN=AZU1 PE=1 SV=3 4.00 26.00 ‐22.00 S10A8_HUMAN Protein S100‐A8 OS=Homo sapiens GN=S100A8 PE=1 14.67 30.50 ‐15.83 SV=1 IL1F9_HUMAN Interleukin‐1 family member 9 OS=Homo sapiens 1.00 15.00 ‐14.00 GN=IL1F9 PE=1 SV=1 MUC5B_HUMAN Mucin‐5B OS=Homo sapiens GN=MUC5B PE=1 SV=3 2.00 14.00 ‐12.00 MUC4_HUMAN Mucin‐4 OS=Homo sapiens GN=MUC4 PE=1 SV=3 1.00 12.00 ‐11.00 HRG_HUMAN Histidine‐rich glycoprotein OS=Homo sapiens GN=HRG 1.00 12.00 ‐11.00 PE=1 SV=1 TKT_HUMAN Transketolase OS=Homo sapiens GN=TKT PE=1 SV=3 17.00 28.00 ‐11.00 CATG_HUMAN Cathepsin G OS=Homo
    [Show full text]
  • Novel Missense Mutation in PTPN22 in a Chinese Pedigree With
    Gong et al. BMC Endocrine Disorders (2018) 18:76 https://doi.org/10.1186/s12902-018-0305-8 RESEARCHARTICLE Open Access Novel missense mutation in PTPN22 in a Chinese pedigree with Hashimoto’s thyroiditis Licheng Gong1†, Beihong Liu2,3†, Jing Wang4, Hong Pan3, Anhui Qi2,3, Siyang Zhang2,3, Jinyi Wu1, Ping Yang1* and Binbin Wang3,4,5* Abstract Background: Hashimoto’s thyroiditis is a complex autoimmune thyroid disease, the onset of which is associated with environmental exposures and specific susceptibility genes. Its incidence in females is higher than its incidence in males. Thus far, although some susceptibility loci have been elaborated, including PTPN22, FOXP3, and CD25, the aetiology and pathogenesis of Hashimoto’s thyroiditis remains unclear. Methods: Four affected members from a Chinese family with Hashimoto’s thyroiditis were selected for whole-exome sequencing. Missense, nonsense, frameshift, or splicing-site variants shared by all affected members were identified after frequency filtering against public and internal exome databases. Segregation analysis was performed by Sanger sequencing among all members with available DNA. Results: We identified a missense mutation in PTPN22 (NM_015967.5; c. 77A > G; p.Asn26Ser) using whole-exome sequencing. PTPN22 is a known susceptibility gene associated with increased risks of multiple autoimmune diseases. Cosegregation analysis confirmed that all patients in this family, all of whom were female, carried the mutation. All public and private databases showed that the missense mutation was extremely rare. Conclusions: We found a missense mutation in PTPN22 in a Chinese HT pedigree using whole-exome sequencing. Our study, for the first time, linked a rare variant of PTPN22 to Hashimoto’s thyroiditis, providing further evidence of the disease-causing or susceptibility role of PTPN22 in autoimmune thyroid disease.
    [Show full text]
  • PROTEOMIC ANALYSIS of HUMAN URINARY EXOSOMES. Patricia
    ABSTRACT Title of Document: PROTEOMIC ANALYSIS OF HUMAN URINARY EXOSOMES. Patricia Amalia Gonzales Mancilla, Ph.D., 2009 Directed By: Associate Professor Nam Sun Wang, Department of Chemical and Biomolecular Engineering Exosomes originate as the internal vesicles of multivesicular bodies (MVBs) in cells. These small vesicles (40-100 nm) have been shown to be secreted by most cell types throughout the body. In the kidney, urinary exosomes are released to the urine by fusion of the outer membrane of the MVBs with the apical plasma membrane of renal tubular epithelia. Exosomes contain apical membrane and cytosolic proteins and can be isolated using differential centrifugation. The analysis of urinary exosomes provides a non- invasive means of acquiring information about the physiological or pathophysiological state of renal cells. The overall objective of this research was to develop methods and knowledge infrastructure for urinary proteomics. We proposed to conduct a proteomic analysis of human urinary exosomes. The first objective was to profile the proteome of human urinary exosomes using liquid chromatography-tandem spectrometry (LC- MS/MS) and specialized software for identification of peptide sequences from fragmentation spectra. We unambiguously identified 1132 proteins. In addition, the phosphoproteome of human urinary exosomes was profiled using the neutral loss scanning acquisition mode of LC-MS/MS. The phosphoproteomic profiling identified 19 phosphorylation sites corresponding to 14 phosphoproteins. The second objective was to analyze urinary exosomes samples isolated from patients with genetic mutations. Polyclonal antibodies were generated to recognize epitopes on the gene products of these genetic mutations, NKCC2 and MRP4. The potential usefulness of urinary exosome analysis was demonstrated using the well-defined renal tubulopathy, Bartter syndrome type I and using the single nucleotide polymorphism in the ABCC4 gene.
    [Show full text]
  • Negative Regulation of Diacylglycerol Kinase &Theta
    Cell Death and Differentiation (2010) 17, 1059–1068 & 2010 Macmillan Publishers Limited All rights reserved 1350-9047/10 $32.00 www.nature.com/cdd Negative regulation of diacylglycerol kinase h mediates adenosine-dependent hepatocyte preconditioning G Baldanzi1,5, E Alchera2,5, C Imarisio2, M Gaggianesi1, C Dal Ponte2, M Nitti3, C Domenicotti3, WJ van Blitterswijk4, E Albano2, A Graziani1,5 and R Carini*,2,5 In liver ischemic preconditioning (IP), stimulation of adenosine A2a receptors (A2aR) prevents ischemia/reperfusion injury by promoting diacylglycerol-mediated activation of protein kinase C (PKC). By concerting diacylglycerol to phosphatidic acid, diacylglycerol kinases (DGKs) act as terminator of diacylglycerol signalling. This study investigates the role of DGK in the development of hepatocyte IP. DGK activity and cell viability were evaluated in isolated rat hepatocytes preconditioned by 10 min hypoxia followed by 10 min re-oxygenation or by the treatment with the A2aR agonist, CGS21680, and subsequently exposed to prolonged hypoxia. We observed that after IP or A2aR activation, a decrease in DGK activity was associated with the onset of hepatocyte tolerance to hypoxia. CGS21680-induced stimulation of A2aR specifically inhibited DGK isoform h by activating RhoA–GTPase. Consistently, both siRNA-mediated downregulation of DGK h and hepatocyte pretreatment with the DGK inhibitor R59949 induced cell tolerance to hypoxia. The pharmacological inhibition of DGK was associated with the diacylglycerol- dependent activation of PKC d and e and of their downstream target p38 MAPK. In conclusion, we unveil a novel signalling pathway contributing to the onset of hepatocyte preconditioning, which through RhoA–GTPase, couples A2aR to the downregulation of DGK.
    [Show full text]
  • SPTLC2 Polyclonal Antibody
    SPTLC2 polyclonal antibody It catalyzes the pyridoxal-5-prime-phosphate-dependent condensation of L-serine and palmitoyl-CoA to Catalog Number: PAB4377 3-oxosphinganine. Mutations in this gene were identified in patients with hereditary sensory neuropathy type I. Regulatory Status: For research use only (RUO) Alternatively spliced variants encoding different isoforms have been identified. [provided by RefSeq] Product Description: Rabbit polyclonal antibody raised against synthetic peptide of SPTLC2. References: 1. Permeability barrier disruption increases the level of Immunogen: A synthetic peptide (conjugated with KLH) serine palmitoyltransferase in human epidermis. corresponding to amino acids 532-562 of human Stachowitz S, Alessandrini F, Abeck D, Ring J, Behrendt SPTLC2. H. J Invest Dermatol. 2002 Nov;119(5):1048-52. 2. Shotgun sequencing of the human transcriptome with Host: Rabbit ORF expressed sequence tags. Dias Neto E, Correa RG, Verjovski-Almeida S, Briones MR, Nagai MA, da Reactivity: Human,Mouse Silva W Jr, Zago MA, Bordin S, Costa FF, Goldman GH, Applications: ELISA, WB-Ti Carvalho AF, Matsukuma A, Baia GS, Simpson DH, (See our web site product page for detailed applications Brunstein A, de Oliveira PS, Bucher P, Jongeneel CV, information) O'Hare MJ, Soares F, Brentani RR, Reis LF, de Souza SJ, Simpson AJ. Proc Natl Acad Sci U S A. 2000 Mar Protocols: See our web site at 28;97(7):3491-6. http://www.abnova.com/support/protocols.asp or product 3. Human and murine serine-palmitoyl-CoA page for detailed protocols transferase--cloning, expression and characterization of the key enzyme in sphingolipid synthesis. Weiss B, Form: Liquid Stoffel W.
    [Show full text]
  • Mapping of Diabetes Susceptibility Loci in a Domestic Cat Breed with an Unusually High Incidence of Diabetes Mellitus
    G C A T T A C G G C A T genes Article Mapping of Diabetes Susceptibility Loci in a Domestic Cat Breed with an Unusually High Incidence of Diabetes Mellitus 1,2, 3, 4 5 Lois Balmer y , Caroline Ann O’Leary y, Marilyn Menotti-Raymond , Victor David , Stephen O’Brien 6,7, Belinda Penglis 8, Sher Hendrickson 9, Mia Reeves-Johnson 3, 3 10 3 3,11, Susan Gottlieb , Linda Fleeman , Dianne Vankan , Jacquie Rand z and 1, , Grant Morahan * z 1 Centre for Diabetes Research, Harry Perkins Institute for Medical Research, University of Western Australia, Nedlands 6009, Australia; [email protected] 2 School of Medical and Health Sciences, Edith Cowan University, Joondalup, Perth 6027, Australia 3 School of Veterinary Science, the University of Queensland, Gottan 4343, Australia; [email protected] (C.A.O.); [email protected] (M.R.-J.); [email protected] (S.G.); [email protected] (D.V.); [email protected] (J.R.) 4 Laboratory of Genomic Diversity, Center for Cancer Research (FNLCR), Frederick, MD 21702, USA; [email protected] 5 Laboratory of Basic Research, Center for Cancer Research (FNLCR), National Cancer Institute, Frederick, MD 21702, USA; [email protected] 6 Laboratory of Genomics Diversity, Center for Computer Technologies, ITMO University, 197101 St. Petersburg, Russia; [email protected] 7 Guy Harvey Oceanographic Center, Halmos College of Arts and Sciences, Nova Southeastern University, Ft Lauderdale, FL 33004, USA 8 IDEXX Laboratories, East Brisbane 4169, Australia; [email protected] 9 Department of Biology, Shepherd University, Shepherdstown, WV 25443, USA; [email protected] 10 Animal Diabetes Australia, Melbourne 3155, Australia; l.fl[email protected] 11 American College of Veterinary Internal Medicine, University of Zurich, 8006 Zurich, Switzerland * Correspondence: [email protected] These authors contributed equally to this work.
    [Show full text]
  • WO 2019/079361 Al 25 April 2019 (25.04.2019) W 1P O PCT
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization I International Bureau (10) International Publication Number (43) International Publication Date WO 2019/079361 Al 25 April 2019 (25.04.2019) W 1P O PCT (51) International Patent Classification: CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, C12Q 1/68 (2018.01) A61P 31/18 (2006.01) DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, C12Q 1/70 (2006.01) HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, (21) International Application Number: MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, PCT/US2018/056167 OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, (22) International Filing Date: SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, 16 October 2018 (16. 10.2018) TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (25) Filing Language: English (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, (26) Publication Language: English GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, (30) Priority Data: UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, 62/573,025 16 October 2017 (16. 10.2017) US TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, ΓΕ , IS, IT, LT, LU, LV, (71) Applicant: MASSACHUSETTS INSTITUTE OF MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TECHNOLOGY [US/US]; 77 Massachusetts Avenue, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, Cambridge, Massachusetts 02139 (US).
    [Show full text]
  • Symbiotic Adaptations in the Fungal Cultivar of Leaf-Cutting Ants
    ARTICLE Received 15 Apr 2014 | Accepted 24 Oct 2014 | Published 1 Dec 2014 DOI: 10.1038/ncomms6675 Symbiotic adaptations in the fungal cultivar of leaf-cutting ants Henrik H. De Fine Licht1,w, Jacobus J. Boomsma2 & Anders Tunlid1 Centuries of artificial selection have dramatically improved the yield of human agriculture; however, strong directional selection also occurs in natural symbiotic interactions. Fungus- growing attine ants cultivate basidiomycete fungi for food. One cultivar lineage has evolved inflated hyphal tips (gongylidia) that grow in bundles called staphylae, to specifically feed the ants. Here we show extensive regulation and molecular signals of adaptive evolution in gene trancripts associated with gongylidia biosynthesis, morphogenesis and enzymatic plant cell wall degradation in the leaf-cutting ant cultivar Leucoagaricus gongylophorus. Comparative analysis of staphylae growth morphology and transcriptome-wide expressional and nucleotide divergence indicate that gongylidia provide leaf-cutting ants with essential amino acids and plant-degrading enzymes, and that they may have done so for 20–25 million years without much evolutionary change. These molecular traits and signatures of selection imply that staphylae are highly advanced coevolutionary organs that play pivotal roles in the mutualism between leaf-cutting ants and their fungal cultivars. 1 Microbial Ecology Group, Department of Biology, Lund University, Ecology Building, SE-223 62 Lund, Sweden. 2 Centre for Social Evolution, Department of Biology, University of Copenhagen, Universitetsparken 15, DK-2100 Copenhagen, Denmark. w Present Address: Section for Organismal Biology, Department of Plant and Environmental Sciences, University of Copenhagen, Thorvaldsensvej 40, DK-1871 Frederiksberg, Denmark. Correspondence and requests for materials should be addressed to H.H.D.F.L.
    [Show full text]
  • IL-17 Induces an Expanded Range of Downstream Genes in Reconstituted Human Epidermis Model
    IL-17 Induces an Expanded Range of Downstream Genes in Reconstituted Human Epidermis Model Andrea Chiricozzi1,2,3*, Kristine E. Nograles1,2, Leanne M. Johnson-Huang1, Judilyn Fuentes-Duculan1, Irma Cardinale1, Kathleen M. Bonifacio1, Nicholas Gulati1, Hiroshi Mitsui1, Emma Guttman-Yassky1,2,4, Mayte Sua´rez-Farin˜ as1,2", James G. Krueger1,2" 1 Laboratory for Investigative Dermatology, The Rockefeller University, New York City, New York, United States of America, 2 Center for Clinical and Translational Science, The Rockefeller University, New York City, New York, United States of America, 3 Department of Dermatology, University of Rome ‘‘Tor Vergata’’, Rome, Italy, 4 Department of Dermatology, Mount Sinai School of Medicine, New York City, New York, United States of America Abstract Background: IL-17 is the defining cytokine of the Th17, Tc17, and cd T cell populations that plays a critical role in mediating inflammation and autoimmunity. Psoriasis vulgaris is an inflammatory skin disease mediated by Th1 and Th17 cytokines with relevant contributions of IFN-c, TNF-a, and IL-17. Despite the pivotal role IL-17 plays in psoriasis, and in contrast to the other key mediators involved in the psoriasis cytokine cascade that are capable of inducing broad effects on keratinocytes, IL-17 was demonstrated to regulate the expression of a limited number of genes in monolayer keratinocytes cultured in vitro. Methodology/Principal Findings: Given the clinical efficacy of anti-IL-17 agents is associated with an impressive reduction in a large set of inflammatory genes, we sought a full-thickness skin model that more closely resemble in vivo epidermal architecture.
    [Show full text]
  • Supplementary Table S4. FGA Co-Expressed Gene List in LUAD
    Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase
    [Show full text]
  • Lipid Related Genes Altered in NASH Connect Inflammation in Liver Pathogenesis Progression to HCC: a Canonical Pathway
    Lipid related genes altered in NASH connect inflammation in liver pathogenesis progression to HCC: a canonical pathway Christophe Desterke1, Franck Chiappini2* 1 Inserm, U935, Villejuif, F-94800, France 2 Cell Growth and Tissue Repair (CRRET) Laboratory, Université Paris-Est Créteil (UPEC), EA 4397 / ERL CNRS 9215, F-94010, Créteil, France. Corresponding author: *Franck Chiappini. Laboratoire du CRRET (Croissance, Réparation et Régénération Tissulaires), Université Paris-Est Créteil, 61 avenue du Général de Gaulle F- 94010, Créteil Cedex, Val de Marne, France. Email address: [email protected]; Tel: +33(0)145177080; Fax: +33(0)145171816 Supplementary Information Supplementary Datasets Table S1: Text-mining list of genes associated in PubMed literature with lipid related keywords. Supplementary Datasets Table S2: Expression fold change of lipid related genes found differentially expressed between NASH and healthy obese liver samples. Supplementary Datasets Table S3: Liver as principal filter for prioritization of lipid related genes found differentially expressed in NASH. Supplementary Datasets Table S4: Gene prioritization secondary filters (immunological, inflammation, liver pathogenesis progression) table found with lipid related genes differentially expressed in NASH. Supplementary Datasets Table S5: Identification of protein partners of YWHAZ gene using InnateDB database. Supplementary Datasets Table S1: Text-mining list of genes associated in PubMed literature with lipid related keywords. Ranking of "lipidic" textmining Gene symbol
    [Show full text]
  • The Roles of Diacylglycerol Kinases in the Central Nervous System: Review of Genetic Studies in Mice
    J Pharmacol Sci 124, 000 – 000 (2014) Journal of Pharmacological Sciences © The Japanese Pharmacological Society Critical Review The Roles of Diacylglycerol Kinases in the Central Nervous System: Review of Genetic Studies in Mice Mitsue Ishisaka1 and Hideaki Hara1,* 1Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu 501-1196, Japan Received November 12, 2013; Accepted January 23, 2014 Abstract. Diacylglycerol kinase (DGK) is an enzyme that converts diacylglycerol to phosphatidic acid. To date, 10 isoforms of DGKs (a, b, g, d, e, z, h, q, i, and k) have been identified in mammals, and these DGKs show characteristic expression patterns and roles. The expression levels of DGKs are comparatively higher in the central nervous system than in other organs and may play several important roles in regulating higher brain functions. Currently, many studies have been performed to reveal the roles of DGKs by knocking down or overexpression of DGKs in vitro. Additionally, knockout or overexpression mice of several DGKs have been generated, and phenotypes of these mice have been studied. In this review, we discuss the roles of DGKs in the central nervous system based on recent findings in genetic models. Keywords: central nervous system, diacylglycerol kinase, genetic mouse, mood disorder 1. Introduction DGKs play unique roles in each isoform. To demonstrate the functions of DGKs, many studies After Gq protein–coupled receptors are stimulated, have been performed using a genetic approach in vitro phospholipase C is activated and produces diacylglycerol and in vivo. To date, several overexpression­ or knockout (DG) from inositol phospholipids (1). DG is an essential (KO)­mice have been generated by many research second messenger in mammalian cells and plays impor­ groups: DGKa­KO (23), cardiac­specific overexpression tant roles in gene transcription, lipid signaling, cyto­ of DGKa (24), DGKb­KO (25), DGKd­KO (26), DGKe­ skeletal dynamics, intracellular membrane trafficking, KO (27), DGKz­KO (28), and DGKi­KO mice (29).
    [Show full text]